Seeing Is Believing
Currently out of the existing stock ratings of Jay Olson, 327 are a BUY (92.63%), 25 are a HOLD (7.08%), 1 are a SELL (0.28%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 45.06% that have a potential upside of 37.98% achieved within 160 days.
Jay Olson’s has documented 771 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 25-Jun-2025.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $20 was fulfilled within 1 day with a profit of $1.3 (6.95%) receiving and performance score of 69.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$37
$16.02 (76.36%)
$42
20 days ago
(25-Jun-2025)
9/16 (56.25%)
$14.79 (66.59%)
238
Buy
$32
$11.02 (52.53%)
$32
20 days ago
(25-Jun-2025)
7/23 (30.43%)
$9.79 (44.08%)
118
Buy
$30
$9.02 (42.99%)
$30
20 days ago
(25-Jun-2025)
0/9 (0%)
$7.79 (35.07%)
Hold
$22
$1.02 (4.86%)
$19
20 days ago
(25-Jun-2025)
16/16 (100%)
$-0.21 (-0.95%)
89
Buy
$30
$9.02 (42.99%)
$25
1 months 10 days ago
(05-Jun-2025)
5/9 (55.56%)
$8.02 (36.49%)
26
Which stock is Jay Olson is most bullish on?
Which stock is Jay Olson is most reserved on?
What Year was the first public recommendation made by Jay Olson?